Ipca Nosedives On Global Fund Sourcing Setback

Shares of Ipca Laboratories plunged on Indian bourses after the firm said that the Global Fund to Fight AIDS, Tuberculosis and Malaria had decided against sourcing certain antimalarials from its Indian sites in view of unresolved quality compliance issues.

More from Anti-infective

More from Therapy Areas